Share on LinkedInShare on LinkedIn

ARTICLE · 17 DECEMBER 2013

eloitte Monday Briefing: What To Read This Christmas

A personal take on economics from Ian Stewart, Deloitte's Chief Economist in the UK.

United KingdomStrategy
  • We are launching our Christmas reading list today. Our six choices offer an eclectic and thought-provoking break from the rigours of Christmas. All are available free and online.
  • The search for new drugs is an expensive and risky process. No wonder pharmaceutical companies hope to be rewarded well when they discover a new drug. But how do companies price a good whose demand does not change with price? This article in the MIT Technology Review provides an insight into the process that prices drugs such as the cystic-fibrosis-fighting Kalydeco at $294,000 a year:
    http://www.technologyreview.com/featuredstory/520441/a-tale-of-two-drugs/
  • These ten charts have, according to this Harvard Business Review article, "changed the way we think". They range from a bar chart of senior managers' worst flaws (the top one being "failure to develop others") to the sharply declining number of successful coups in Africa:

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from